Abbott Laboratories PE ratio ABT

Share price divided by earnings per share over the last twelve months, since 1998.

Today, Oct 23, 2026: 38.7×
10-year median: 36.7×
Against its 10-year history: 54th; percentile: 0 is its lowest day, 100 its highest
10-year range: 13.5× to 261×
Peer median: 24.0×

Abbott Laboratories' PE ratio is 38.7× as of Oct 23, 2026: a share price of $103.70 against $2.68 of earnings per share over the last twelve months.

That is above its ten-year median of 36.7×, close to the middle of its last ten years.

Over that time it ranged from 13.5× in Jan 2026 to 261× in Jul 2018.

The median for 7 medical device stocks of a similar size is 24.0×.

PE ratio over time

median 36.7×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	38.7×	13.5×	38.7×
2025	15.6×	15.5×	41.0×
2024	35.0×	31.8×	39.0×
2023	37.4×	24.1×	37.4×
2022	24.8×	19.8×	33.6×
2021	34.9×	30.9×	67.8×
2020	57.9×	33.0×	64.0×
2019	47.5×	44.9×	159×
2018	148×	45.0×	261×
2017	44.9×	43.0×	79.3×
2016	42.2×	12.4×	44.1×
2015	15.0×	13.7×	37.4×
2014	36.1×	19.2×	36.3×
2013	20.1×	8.0×	20.1×
2012	7.5×	7.3×	11.1×
2011	9.3×	7.2×	9.3×
2010	7.6×	6.5×	8.1×
2009	n/m a value too high to mean anything
2008	20.7×	19.7×	23.5×
2007	22.3×	11.6×	28.4×

Against its peers

Companies in Medical - Devices nearest Abbott Laboratories' size, closest first, today.

Company	PE ratio
ABTAbbott Laboratories	38.7×
MDTMedtronic	23.4×
SYKStryker	31.8×
BSXBoston Scientific	18.5×
EWEdwards Lifesciences	51.2×
GEHCGE HealthCare Technologies	16.4×
DXCMDexCom	30.9×
ZBHZimmer Biomet	24.0×
Peer median	24.0×

Where Abbott Laboratories ranks

#12of 13Medical device stocks with the lowest PE ratio

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Abbott Laboratories

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.